GLOBUS MEDICAL INC (GMED) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K/A	10-K	10-K
Revenues:
Non Us	150.9	138.5	124.6	137.7	119.1	106.1
Innovative Fusion								288.1
Disruptive Technology								256.7
Other	871.9	819.6	664.5	647.7	593.9	529.9
Total revenues	1,022.8	958.1	789.0	785.4	713.0	636.0	564.0	544.8
Revenue growth [+]	6.8%	21.4%	0.5%	10.2%	12.1%	12.8%	3.5%	14.8%
Non Us	8.9%	11.2%	-9.5%	15.6%	12.2%
Innovative Fusion								6.4%
Disruptive Technology								26.1%
Cost of goods sold	263.7	239.2	217.5	180.0	159.4	150.5	134.7	132.3
Gross profit	759.1	718.9	571.6	605.4	553.6	485.5	429.3	412.4
Gross margin	74.2%	75.0%	72.4%	77.1%	77.6%	76.3%	76.1%	75.7%
Selling, general and administrative	531.2	546.9	460.1	433.4	384.2	323.7	222.2	210.2
Research and development							44.5	36.3
Other operating expenses	-13.4	-42.2	-38.1	-17.5	-13.6	-9.2	6.6	-9.7
EBITDA [+]	309.6	284.0	212.4	242.2	224.6	213.1	194.7	199.7
EBITDA growth	9.0%	33.7%	-12.3%	7.8%	5.4%	9.4%	-2.5%	25.4%
EBITDA margin	30.3%	29.6%	26.9%	30.8%	31.5%	33.5%	34.5%	36.7%
Depreciation	50.5	51.3	46.0	38.9	32.0	34.2	35.3	22.5
EBITA	259.0	232.7	166.4	203.3	192.6	178.9	159.4	177.1
EBITA margin	25.3%	24.3%	21.1%	25.9%	27.0%	28.1%	28.3%	32.5%
Amortization of intangibles	17.7	18.5	16.8	13.8	9.6	7.9	3.5	1.6
EBIT [+]	241.3	214.1	149.5	189.5	183.0	171.0	156.0	175.6
EBIT growth	12.7%	43.2%	-21.1%	3.6%	7.0%	9.6%	-11.2%	27.8%
EBIT margin	23.6%	22.4%	19.0%	24.1%	25.7%	26.9%	27.7%	32.2%
Non-recurring items [+]	0.2	34.3	24.4			0.5	1.8	3.4
Asset impairment						0.5
Interest income, net [+]						0.0	3.1	1.3
Interest expense						0.0
Interest income							3.1	1.3
Other income (expense), net [+]	1.9	0.6	0.8	0.5	5.6	-0.6	0.1	-0.7
Gain (loss) on foreign currency transactions							-0.5	-1.2
Other non-operating income	1.9	0.6	0.8	0.5	5.6	0.6	0.6	0.4
Other	1.9	0.6	0.8	0.5	5.6	-0.6	3.1	0.6
Pre-tax income	243.0	180.4	125.9	189.9	188.6	169.9	157.3	172.8
Income taxes	52.9	31.2	23.6	34.7	32.1	62.6	52.9	60.0
Tax rate	21.7%	17.3%	18.8%	18.3%	17.0%	36.8%	33.7%	34.7%
Net income	190.2	149.2	102.3	155.2	156.5	107.3	104.3	112.8
Net margin	18.6%	15.6%	13.0%	19.8%	21.9%	16.9%	18.5%	20.7%

Basic EPS [+]	$1.89	$1.48	$1.04	$1.57	$1.60	$1.12	$1.09	$1.19
Growth	27.8%	42.7%	-33.7%	-2.1%	43.3%	2.2%	-8.1%	20.9%
Diluted EPS [+]	$1.85	$1.44	$1.01	$1.52	$1.54	$1.10	$1.08	$1.17
Growth	28.7%	42.1%	-33.4%	-1.5%	40.8%	1.4%	-7.8%	21.2%

Shares outstanding (basic) [+]	100.5	100.7	98.6	99.2	97.9	96.2	95.6	95.0
Growth	-0.3%	2.2%	-0.6%	1.3%	1.7%	0.6%	0.6%	0.9%
Shares outstanding (diluted) [+]	102.6	103.6	101.0	102.0	101.3	97.9	96.4	96.1
Growth	-0.9%	2.6%	-1.0%	0.7%	3.5%	1.5%	0.4%	0.6%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.